Emerging Therapies in Diffuse Large B-cell Lymphoma (DLBCL) Advisory Board

Activity: Consultancy, spin-outs, CPD & licensingConsultancy & ServicesResearch

Period25 Jun 2020
Work forKaryopharm Therapeutics Inc. , United States
Degree of RecognitionInternational